A cell line (Kasumi-3) established from acute myeloid leukemia (AML-M0) had unique phenotypes of undifferentiated leukemia cells with expression of both T cell and myeloid antigens. Kasumi-3 cells with t(3;7)(q26;q22) highly expressed a 6 kb transcript of EVI1, which is located on chromosome 3q26. Therefore, we further characterized the chromosomal breakpoint by pulsed-field gel electrophoresis near EVI1. We identified and isolated the chromosomal breakpoint at approximately 80 kb upstream from the 5Ј end of EVI1. Sequence analysis of the breakpoint revealed that the whole V␤ region from T cell receptor beta (TCR␤) at 7q35 was translocated to the upstream of EVI1. A 1.0 kb TCR␤ transcript was expressed in the Kasumi-3 cells, suggesting that TCR␤ rearrangement occurred as D␤-J␤ joining events. Fluorescence in situ hybridization analysis revealed that the inverted chromosome 7q22-q35 segment between TCR␤ and the region proximal to the erythropoietin gene at 7q22 was translocated to the region distal to EVI1 in der(3). Since the telomeric region of chromosome 8 q was also translocated to the inverted chromosome 7q22-q35 segment in der(3), the chromosomal abnormalities of der(3) were defined as being der(3)t(3;7;8)(3pter-3q26::7q35-7q22::8q22-8qter). It is suggested that a translocated enhancer element in the TCR␤ locus and/or loss of a negative regulatory element near EVI1 might function to enhance the EVI1 expression. Therefore, the enhanced EVI1 expression may contribute to the development of a subset of undifferentiated leukemia.
Introduction
The proto-oncogene EVI1 was initially identified as being activated in murine myeloid leukemia by proviral insertions in the Evi-1 common viral integration site. 1 In human leukemia, the EVI1 gene is activated in myeloid leukemia (M1 to M7) and myelodysplastic syndromes (MDS) by chromosomal rearrangements at either the 5Ј region of the gene in t(3;3)(q21;q26) or the 3Ј region of the gene in inv(3)(q21q26) by juxtaposition of the EVI1 gene to enhancer elements in the 3q21 region with the Ribophorin I gene. 2, 3 Moreover, the fusion gene, AML1/MDS1/EVI1, was activated in chronic myelogenous leukemia-blastic crisis (CML-BC) 4 or MDS 5 with t(3;21) translocation, and TEL/MDS1/EVI1 was activated in acute myeloid leukemia with t(3;12) translocation. 6 Although the exact mechanism by which EVI1 exerts its leukemogenic effect is not clear, it may involve inhibition of terminal differentiation through the abnormal repression of genes necessary for cellular maturation. 7, 8 Therefore, the EVI1 gene is one of the leukemogenic genes mapped to 3q26 and activated in AML, MDS and CML-BC through chromosomal abnormalities involving 3q26.
Translocational breakpoints of t(3;3) or t(3;12) or t(3;21) spanned around 300 to 400 kb at the 5Ј region of EVI1, and the breakpoints of inv(3)(q21q26) spanned from the 3Ј end of the coding region to around 200 kb downstream of EVI1. In cases of t (3;21) , the 5Ј region of the AML1 gene was translocated to upstream of the EVI1 gene, and the AML1 gene was fused with multiple genes (EAP, MDS1 and EVI1). 5 In cases of t (3;12) , some cases showed that the 5Ј region of the TEL gene was fused with MDS1 and EVI1, 6 but other cases showed that only the promoter region of the TEL gene translocated upstream of the EVI1 gene without making any fusion transcripts. 9 In 3q21q26 syndrome, the 3q21 region containing Ribophorin I (RPN1) translocated to upstream of EVI1 in the cases with t(3;3), but the same region was translocated to downstream of EVI1 in the cases with inv(3), suggesting that the translocated 3q21 region containing RPN1 might activate expression of EVI1 in the cases with both t(3;3) and inv(3) as the transcripitonal enhancer mechanism. Based on the reports of these leukemia cases with translocations at 3q26, it is suggested that EVI1 expression in these cases with t(3;3), inv(3), t(3;12), or t(3;21) might be activated by the translocated promoter or enhancer region(s).
Recently, a unique undifferentiated leukemia cell line (AML-M0), Kasumi-3, was established by our group. 10 It has a unique chromosomal abnormality of t(3;7)(q27;q22) with other additional chromosomal abnormalities. In this study, we showed that the EVI1 gene was transcriptionally activated in Kasumi-3 cells to the same level as that in UCSD/AML1 cells and we identified that the translocation breakpoint was located at 80 kb upstream of the EVI1 gene at 3q26 and at the 70-kb region between the V␤ and D␤ elements of the T cell receptor (TCR) ␤ gene at chromosome 7q35. A 1.0 kb TCR␤ transcript was expressed in the Kasumi-3 cells, suggesting that TCR␤ gene rearrangement might have occurred as a D␤-J␤ joining event. The promoter region with whole V␤ elements of TCR␤ gene was translocated to upstream of the EVI1 gene and might contribute to activating EVI1 expression. Moreover, the inverted chromosome 7q22-q35 segment between the TCR␤ gene and the region proximal to the erythropoietin gene at 7q22 was translocated to the region distal to the EVI1 gene with the telomeric region of chromosome 8 q in der(3)t(3;7;8). Therefore, activation of the EVI1 gene by translocation of the TCR␤ gene was suggested to be one of the pathogenetic mechanisms for the development of a part of undifferentiated myeloid leukemia.
Materials and methods

Kasumi-3 cells and other cell lines
Kasumi-3 was established and the phenotype previously analyzed in detail. 10 Briefly, flow cytometric analysis showed cell surface expression of CD4, CD7, CD13, CD33, CD34, HLA-DR and c-kit. The cytogenetic study indicated that Kasumi-3 cells carried chromosomal abnormalities of t(3;7)(q27;q22), del(5)(q15), del(9)(q32) and add(12)(p11). Kasumi-3 cells proliferated by treatment of IL-2, IL-3, IL-4, granulocyte-macrophage colony-stimulating factor (GM-CSF) and stem cell factor (SCF), suggesting that the cells have the characteristics of undifferentiated leukemia. Cells were maintained in Iscove's modified Dulbecco's Eagle medium (IMDM) with 10% fetal bovine serum at 37°C in humid conditions in a 5.0% CO 2 atmosphere.
The UCSD/AML1 cell has been described as an acute myeloid leukemia with t(3;3)(q21;q26). 11 The F36 cell line has been established as factor-dependent myeloid leukemia cells. 12 The KP-L-RY cell line was kindly provided by Drs Imashuku and Ikushima, Kyoto Prefectural University of Medicine. HEL, Jurkat, SKW3 and MOLT16 cell lines were kindly provided by Drs Matsuo and Minowada at Hayashibara Biochemical Laboratories.
Southern and northern blot analysis
High molecular weight DNA was extracted from mononuclear cells (MNCs) of a normal donor and cell lines by proteinase K digestion and phenol/chloroform extraction. 13 Ten micrograms of DNA were digested with appropriate restriction enzymes, subjected to electrophoresis on 0.8 or 1.0% agarose gel, transferred to charged nylon filters (Pall BioSupport, Port Washington, NY, USA), and hybridized to DNA probes labeled by the random hexamer method. mRNA was extracted from cells growing in culture using the FastTrack 2.0 mRNA isolation kit according to the manufacturer's instructions (Invitrogen, Carlsbad, CA, USA). Approximately 5 g of mRNA was denatured with 37% formamide/15% formaldehyde and was electrophoresed on 1% agarose gel containing 17% formaldehyde. mRNA was transferred to nylon filters. The filters were hybridized with a [␣-32 P] dCTP-labeled human EVI1 and ␤-actin probes and were exposed to Kodak Biomax film (Kodak, Rochester, NY, USA) at −70°C. Pre-hybridization, hybridization and posthybridization washes were performed as described. 3 
Isolation of phage clones
Approximately 5 × 10 5 recombinant phages of an EMBL3 human genomic DNA library from normal peripheral blood cells were screened with the 32 P-labeled probe according to standard procedures. 11 Hybridization with a random-primerlabeled probe was performed at 42°C in 6 × standard saline citrate (SSC)/10% dextran sulfate/1% sodium dodecyl sulfate (SDS)/1 × Denhardt's solution/50% formamide containing denatured salmon sperm DNA (100 mg/ml). When probes containing repetitive sequences were used, human placenta DNA was added to the hybridization mixture. The final washing was in 0.1 × SSC/0.1% SDS at 65°C. Autoradiography was performed using a Bioimage analyzer, Fujix BAS2000 (Fuji Film, Tokyo, Japan). 
Screening of P1 clones
Human P1 library (series B; Du Pont, Boston, MA, USA) was screened by a PCR-based strategy.
14 Amplification was performed by 35 cycles in a thermal cycler (Perkin Elmer, Foster City, CA, USA) under the cycling conditions of 1 min at 94°C, 1 min at 55°C, and 2 min at 72°C. Primer sequences were as follows: C-forward: 5Ј-TCACAACCAGAATCCAGACC-3Ј; Creverse: 5Ј-CATTGAGGGCCAGG-TTACTA-3Ј. P1 DNAs were prepared by a standard alkaline lysis method.
Nucleotide sequencing
Nucleotide sequences of genomic phage clones were determined by the PCR cycling DNA sequence method with the fmol DNA Sequencing System (Promega, Madison, WI, USA), based on the dideoxynucleotide chain termination reaction. 13 
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Fluorescence in situ hybridization (FISH)
Chromosomal mapping of the genomic clones was performed on R-banded metaphase. To confirm the origin of cloned DNAs, we also mapped the genomic clones with Kasumi-3 cellsЈ metaphase chromosomes. FISH analysis was carried out as described previously. 15 
Probes
The C␤ probe for detecting the TCR␤ gene expression was a 720-bp fragment, isolated from the HBVT 96 cDNA clone, 16 which was kindly provided by Dr Kimura, the First Department of Internal Medicine, Fukuoka University School of Medicine. The EVI1 probe for Northern blot hybridization was derived from a human cDNA clone (H1-1) as previously described, 3 and a 300-bp fragment of MDS1 was derived from amplified cDNA by reverse transcriptase-PCR (RT-PCR). Amplification was performed by 35 cycles in a thermal cycler (Perkin Elmer) under the cycling conditions of 1 min at 94°C, 1 min at 55°C, and 2 min at 72°C. Primer sequences were as follows: MDS1F1: 5Ј-ACTGGGCACAGCATGAGATC-3Ј; MDS1R1: 5Ј-TCCCATCCATAACTGGGGTC-3Ј.
Three DNA probes for pulsed-field gel electrophoresis (PFGE) analysis were previously described. 2 Briefly, the human FIM3 probe is a 0.5 kb single copy clone, which is derived from the murine fim-3 equivalent region. The B3N probe is a 1.0 kb single copy fragment isolated from the breakpoint of UCSD/AML-1 cells. H1-1 is a cDNA clone of the EVI1 gene.
Results
Expression of EVI1 transcripts in Kasumi-3 cells
Since the Kasumi-3 cell line was found to have translocation t(3;7)(q26;q22), we initially determined expression of the EVI1 gene by Northern hybridization. As shown in Figure 1a , expression of a major 6 kb EVI1 transcript in Kasumi-3 was detected to the same level as that in the UCSD/AML1 cells with t(3;3)(q21;q26). 2 No other cell lines (three lymphoid and two myeloid cell lines) expressed a high level of EVI1 transcripts, except HEL cells with weak expression of EVI1. A MDS1 or MDS1/EVI1 transcript was not detected by Northern blot hybridization (data not shown). Therefore, it is possible that EVI1 transcripts in leukemia cells were activated by chromosomal translocation at the 3q26 region. Next, we performed pulsed-field gel electrophoresis (PFGE) to identify the chromosomal breakpoint near EVI1 in Kasumi-3 cells.
Identification of the chromosomal breakpoint
To identify the chromosomal breakpoint, we performed PFGE using three probes, H1-1 EVI1 cDNA, B3N and FIM3 ( Figure  2a) . 3 The H1-1 EVI1 cDNA probe detected a rearranged band in SfiI-digested DNA, but did not detect any rearranged band in BssHII-digested DNA (Figure 1c) . The B3N probe detected the same rearranged band in SfiI-digested DNA and a novel rearranged band with a germ line band in BssHII-digested DNA, suggesting that the chromosomal breakpoint was localized between the CpG island at the 5Ј end of the EVI1 gene and the SfiI site of 170 kb upstream from the EVI1 gene (Figure 1c) . However, the FIM3 probe did not detect a rearranged band but only detected a germ line band, suggesting that the region with the FIM3 fragment was deleted in the rearranged allele. Thus, it is likely that the chromosomal breakpoint at 3q26 is localized at the region between the B3N and FIM3 probes, if the translocation at 3q26 was accompanied by deletion of the FIM3 region.
To identify the chromosomal breakpoint of t(3;7), we isolated 80 kb of a P1 genomic clone (70-1) covering the region between the FIM3 locus and the B3N probe (Figure 2a ). Since the B3N probe was located 15 kb upstream from the 5Ј end of the EVI1 gene, the distance between exonl of EVI1 and the FIM3 locus was estimated as approximately 100 kb. The 3.5 kb Bam H1 fragment (designated P2) in the 70-1 clone detected rearranged bands in DNA digested with BamHI and HindIII by Southern blot analysis (Figure 1d ). The P2 probe was localized at approximately 80 kb upstream from the 5Ј end of the EVI1. The sizes of rearranged BamHI and HindIII fragments were 14 kb and 8 kb, respectively. We could not find a rearranged fragment in the EcoRI-digested DNA, since the size of a rearranged fragment was almost the same as that of the germ line fragment by EcoRI digestion. Only one rearranged fragment was detected in DNA with BamHI or HindIII digestion by the P2 probe. Since the FIM3 probe did not hybridize to both der(3) and der(7) chromosomes by FISH analysis (data not shown), it is likely that the other side of the translocated allele surrounding the breakpoint was deleted with the FIM3 locus.
The TCR␤ locus was translocated to chromosome 3q26 with expression of the TCR␤ gene in Kasumi-3 cells
Using the P2 probe, a 14 kb fragment was isolated from a Bam-HI complete-digested genomic DNA library of Kasumi-3 cells. The isolated 14 kb clone was derived from der(3)t(3;7) (Figure 2c ). The translocational breakpoint was determined by comparison of the restriction map between the germ line chromosome 3 (Figure 2b ) and the rearranged BamHI fragment (Figure 2c ). We sequenced a region surrounding the breakpoint in the phage clone and performed FISH analysis of this fragment to determine the chromosome location of the translocation counterpart. By comparison of the sequence around the breakpoint with that of the DNA database in GenBank, it was revealed that the sequence along with the breakpoint completely matched the T cell receptor ␤ locus at chromosome 7q34-35 (Figure 2f ). Based on the physical map of the TCR␤ locus reported previously, 17 the breakpoint was mapped within the 70-kb region between the V␤4S1 and D␤1 elements (Figure 2d and e) . The centromeric region of the TCR␤ locus with the entire V␤ region was translocated to the telomeric side of the EVI1 gene at chromosome 3q26, suggesting that the translocated part of the long arm of chromosome 7 with the TCR␤ locus was possibly inverted in chromosome der(3). Furthermore, we confirmed that the genomic clone containing the chromosomal breakpoint was hybridized to chromosome 7q35 by FISH analysis (data not shown).
To determine whether the TCR␤ gene was expressed in the Kasumi-3 cells, Northern blot hybridization was performed using a C␤ probe from TCR␤ cDNA. As shown in Figure 1b , a 1.3 kb of full-length TCR␤ transcript was detected in two T cell leukemia cell lines (Jurkat, MOLT16) but around 1.0 kb of TCR␤ transcript was detected in the mRNA from SKW3 and Kasumi-3 cell lines. The short 1.0 kb transcript was reported to be derived from the D␤-J␤-C␤ joining event without the V␤ region. 18 Based on these results, it was suggested that the whole V␤ region with promoter from the TCR␤ locus at 7q35 was translocated to the upstream of the EVI1 gene with expression of the TCR␤ and EVI1 genes.
Sequence analysis of chromosomal breakpoints
Translocation preferentially occurs in regions that have DNA sequences with homology to nonamer and heptamer signal sequences in T cell malignancy. 19 The germ line DNA sequence at chromosome 3 was analyzed for both structural motifs. However, a definite set of heptamer and nonamer sequences was not found in the germ line sequence of chromosome 3q26 (Figure 2f ). An imperfect heptamer sequence (CACTTAT vs the predicted CAC A / T GTG) was present adjacent to the breakpoint at 3q26, and a nonamer-like sequence (TGTTTTTGA vs predicted GGTTTTTGC) was present at the other side of the breakpoint at 3q26. On the other hand, an imperfect heptamer sequence (CACTAAA) and a nonamer-like sequence (GGTTTAGTG) were also found near the breakpoint at chromosome 7q35. Since complete matched heptamer and nonamer sequences were not found surrounding the breakpoint, the sequence data did not support the idea that abnormality of V-D-J recombinase was important in the development of an aberrant rearrangement in this case.
An inverted and translocated segment of chromosome 7(q22q35) was identified by FISH analysis in der(3)t(3;7;8)
Since a part of the long arm of chromosome 7 with the TCR␤ locus was possibly inverted in the der(3) chromosome, we performed FISH analysis of Kasumi-3 metaphasic chromosomes using painting probes for chromosome 3 and chromosome 7. The painting probe for chromosome 3 hybridized to the short arm and a half of the long arm of der(3), and a part of chromosome 7 (red in Figure 3a and e) was hybridized at the proximal end of der(3) (green in Figure 3a and d) . However, the distal end of der(3) did not hybridize both probes, suggesting that a part from an unknown chromosome was translocated to the telomeric end of the der(3). To confirm which chromosome was translocated at the end of der(3), we used many painting probes, and finally the probe for chromosome 8 (pBS8) did hybridize the telomeric part of der(3). A part of chromosome 8 (green color in Figure 3f ) was hybridized at the telomeric end of der(3) (red in Figure 3f by the painting probe for chromosome 3) with a gap of another chromosome, which was hybridized by the probe for chromosome 7 (red in Figure 3g ). G-banding pattern of der(3) indicated that segment 8q22-ter was involved in this complex chromosomal rearrangement. To confirm the direction of translocated chromosome 7 in der(3), we hybridized a genomic phage clone with the erythropoietin gene (EPO) at chromosome 7q22 as a probe. The EPO probe hybridized to the region adjacent to the distal chromosomal breakpoint at the region between chromosome 7 and chromosome 8 in der(3) (Figure 3h and i) , suggesting that a part of the chromosome 7q22-q35 segment with the EPO gene was inverted and translocated to der(3)t(3;7;8) (Figure 3j) . Therefore, the distal breakpoint of the inverted chromosome 7q22-q35 segment in der(3)t(3;7;8) was localized within the TCR␤ locus at 7q35 next to the EVI1 gene on chromosome 3q26, and the proximal breakpoint was localized centromeric to the EPO gene at 7q22. Finally, the der(3) chromosome was defined as being der(3)t(3;7;8)(3pter→3q26::7q35→7q22::8q22→8qter) ( Figure  3j ).
Discussion
In this study, we showed a unique translocation of t(3;7;8), involving the TCR␤ gene and the EVI1 gene, in the undifferentiated myeloid leukemia cell line, Kasumi-3. The whole V␤ region of the TCR␤ gene at chromosome 7q35 was translocated to upstream of the EVI1 gene and the chromosomal aberrancy near EVI1 might have an important role for activation of the EVI1 expression. Until now, we had examined expression of the EVI1 gene in several leukemia cells and found Kasumi-3 cells only in the case of FAB-M0 with expression of the EVI1 gene. Furthermore, the long arm of Fluorescence in situ hybridization analysis of leukemia metaphase chromosomes. Dual-color FISH analysis revealed that a part of chromosome 7 (red) translocated at the telomeric side of der(3) (green) (a). Each probe hybridization was confirmed by single-color FISH analyses (d and e). Each derivative chromosome was confirmed by Q-banded chromosomes (b) and also a part of chromosome 7 (red) was translocated to der(3) using Q-banded chromosomes (c). The telomeric end of der(3) was derived from chromosome 8 (green), which was detected by the painting probe (pBS8) (f). Arrows with a and b in panel (f) indicate der(3). The painting probe for chromosome 3 was hybridized to der(3) by red in dual color (f). Chromosomes 7 and 8 are indicated as red and green, respectively (g) and each chromosome was confirmed by Q-banded chromosomes. The EPO gene (arrows) was assigned to band 7q22 on normal chromosome 7 (small arrow) and to the distal breakpoint on der(3)t(3;7;8), which is next to the region of chromosome 8 (q22-ter) (large arrow) (h). The chromosome bandings were confirmed using Q-banded chromosomes (i). Schematic representation of chromosomal rearrangements in Kasumi-3 cells with der(3)t(3;7;8) (j). chromosome 7 between the centromeric side of the EPO gene at 7q22 and the TCR␤ locus was inverted and translocated in der(3)t(3;7;8). Therefore, the translocated TCR␤ locus and/or deletion of the 5Ј region of the EVI1 gene may enhance the EVI1 gene expression and may contribute to leukemogenesis of a subset of AML-M0.
Disregulation of proto-oncogene by translocation of the TCR gene was originated by at least two mechanisms. One is that the enhancer element at the 3Ј end of the TCR␤ gene was translocated to the 5Ј or 3Ј region of proto-oncogenes, as in the case of the LYL1, 20 TAL1, 21 and LCK genes. 22, 23 The other is that the V region of the TCR␤ gene without the usual enhancer element was translocated near the Rhom-1 and Rhom-2 genes. 24, 25 In these cases, the TCR enhancer element at the 3Ј end of the TCR␤ gene cannot influence the expression of these proto-oncogenes, but it is suggested that the loss of a negative regulatory element or generation of a cryptic promoter/enhancer may contribute to the activation of these genes. Since the breakpoint was located at approximately 80 kb upstream from the 5Ј end of the EVI1 gene, and enhancer or promoter elements were translocated near the EVI1 gene in other leukemia cases with t(3;3), inv(3), t(3;12) or t(3;21), it is suggested that an unknown enhancer element in the TCR␤ locus translocated near the EVI1 gene and/or loss of a negative regulatory element might contribute to transcriptional activation of the EVI1 gene.
It is a unique finding that the TCR␤ locus was translocated to the 5Ј region of the EVI1 gene with activation of the EVI1 expression in AML-M0. This is the first report that the TCR␤ locus was rearranged to the locus of a proto-oncogene in AML-M0. Since patients with AML-M0 have frequently been found to have complex karyotypes and unbalanced chromosome changes involving abnormalities of 5 q or 7 q, [26] [27] [28] [29] Kasumi-3 is a typical case of complex abnormalities of der(3)t(3;7;8) with insertion of the inverted chromosome 7q22-q35 segment and/or del(5)(q15). Thus, these findings indicate that EVI1 gene activation with complex chromosomal abnormalities might contribute to the leukemogenesis of Kasumi-3 cells.
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